Hardman Johnston Global Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-22,160
| Closed | -$2.56M | – | 82 |
|
2020
Q4 | $2.56M | Sell |
22,160
-46,820
| -68% | -$5.4M | 0.07% | 54 |
|
2020
Q3 | $6.72M | Buy |
68,980
+6,960
| +11% | +$678K | 0.25% | 49 |
|
2020
Q2 | $7.61M | Buy |
62,020
+8,290
| +15% | +$1.02M | 0.34% | 48 |
|
2020
Q1 | $4.71M | Sell |
53,730
-9,180
| -15% | -$804K | 0.27% | 46 |
|
2019
Q4 | $6.58M | Buy |
62,910
+3,860
| +7% | +$404K | 0.27% | 47 |
|
2019
Q3 | $6.79M | Buy |
59,050
+3,990
| +7% | +$459K | 0.31% | 44 |
|
2019
Q2 | $9.49M | Buy |
55,060
+17,810
| +48% | +$3.07M | 0.42% | 43 |
|
2019
Q1 | $6.28M | Buy |
37,250
+6,280
| +20% | +$1.06M | 0.28% | 47 |
|
2018
Q4 | $3.02M | Sell |
30,970
-3,520
| -10% | -$343K | 0.16% | 48 |
|
2018
Q3 | $5.96M | Buy |
34,490
+11,320
| +49% | +$1.96M | 0.26% | 45 |
|
2018
Q2 | $3.23M | Buy |
+23,170
| New | +$3.23M | 0.14% | 47 |
|